3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with prostaglandin h2 in 1 studies
Studies (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Trials (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Recent Studies (post-2010) (3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid) | Studies (prostaglandin h2) | Trials (prostaglandin h2) | Recent Studies (post-2010) (prostaglandin h2) |
---|---|---|---|---|---|
36 | 1 | 1 | 413 | 0 | 34 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aksoy, MO; Harakal, C; Smith, JB; Stewart, GJ; Zerweck, CR | 1 |
1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and prostaglandin h2
Article | Year |
---|---|
Mediation of bradykinin-induced contraction in canine veins via thromboxane/prostaglandin endoperoxide receptor activation.
Topics: Animals; Bradykinin; Bridged Bicyclo Compounds, Heterocyclic; Dogs; Endothelium, Vascular; Fatty Acids, Unsaturated; Female; Hydrazines; Imidazoles; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Prostaglandin Endoperoxides; Prostaglandin Endoperoxides, Synthetic; Prostaglandin H2; Prostaglandin-Endoperoxide Synthases; Prostaglandins H; Pyridines; Receptors, Prostaglandin; Sulfonamides; Thromboxane-A Synthase; Thromboxanes; Veins | 1990 |